2 not yet recruiting, 1 completed, 1 recruiting, 1 withdrawn. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Not yet recruiting 2, Completed 1, Withdrawn 1 |
Follow Advanced Biliary Tract Cancer(BTC): new trials by email Literature Review of Advanced Biliary Tract Cancer(BTC) trials Research Report on Advanced Biliary Tract Cancer(BTC)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nivolumab Plus Relatlimab and Gemcitabine/Cisplatin as First-Line Treatment in Advanced Biliary Tract Cancer. Nivolumab, Gemcitabine, Cisplatin - Advanced Biliary Tract Cancer(BTC) | Phase 2 | Withdrawn | National Health Research Institutes, Taiwan | 2026-12-01 | 2026-07-02 | |
| Sacituzumab Tirumotecan in Previously Treated TROP2-Positive Advanced Biliary Tract Cancer Sacituzumab Tirumotecan (SKB264) - Advanced Biliary Tract Cancer(BTC) | Phase 2 | Not yet recruiting | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 33 | 2026-07-01 | 2026-07-14 |
| A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Biliary Tract Cancers Organoid Drug Sensitivity Testing-Guided Therapy - Advanced Biliary Tract Cancer(BTC) | Phase 2 | Not yet recruiting | Eastern Hepatobiliary Surgery Hospital | 88 | 2026-01-30 | 2026-01-20 |
| A Prospective Observational Study of First-Line Systemic Therapy Combined With Celiac Plexus Blockade for Advanced Biliopancreatic Cancer With Pain First-Line Systemic Therapy, Celiac Plexus Neurolysis (CPN) - Advanced Biliary Tract Cancer(BTC), Advanced Pancreatic Cancers | Recruiting | Tongji Hospital | 103 | 2025-12-26 | 2026-02-11 | |
| A Study of S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract Cancer S-1/Gemcitabine - Advanced Biliary Tract Cancer(BTC) | Phase 2 | Completed | TTY Biopharm | 51 | 2015-04-01 | 2019-08-21 |
Biliary Tract Neoplasms (1) · Cancer Pain (1)
Biliary Tract Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Neurologic Manifestations (1) · Pain (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Cisplatin (1) · Gemcitabine (1) · Nivolumab (1) · relatlimab (1)
Eastern Hepatobiliary Surgery Hospital (1) · National Health Research Institutes, Taiwan (1) · TTY Biopharm (1) · Tongji Hospital (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)
Taiwan (2) · China (1)
Feng Shen (1) · Li-Tzong Chen, M.D. (1) · Ming-Huang Chen, MD, PhD, (1)